Trial intelligence / Profile preview

Januvia and Bone Turnover in Postmenopausal Women With Type 2 Diabetes

NCT01374568Phase 4Terminated

Sponsor
University of Alabama at Birmingham
Start
Jul 2010
Primary completion
Jul 2012
Countries
1
01

Overview

A Phase 4 trial of sitagliptin in type 2 diabetes mellitus (T2DM), sponsored by University of Alabama at Birmingham. Started Jul 2010; status: terminated.

02

Drugs

sitagliptin
03

Conditions

type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on NCT01374568.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01374568.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call